Atlas Trials

Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds

Clinical trial NCT05800834 · UNKNOWN

Trial details

NCT number
NCT05800834
Sponsor
Instituto Nacional de Cancer, Brazil
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Wounds and InjuriesCancer PainCancer, BreastCancer Head Neck
Start date
2023-09-12
Primary completion
2024-03-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.